Brief: Expres2ion Says A Rights Issue Of Units Of Approximately SEK 102.4 Mln
03/03/2023 19:24
March 3 (Reuters) - ExpreS2ion Biotech Holding AB
EXPRS2.ST :
* EXPRES2ION ANNOUNCES A RIGHTS ISSUE OF UNITS OF
APPROXIMATELY
SEK 102.4 MILLION
* SUBSCRIPTION PRICE HAS BEEN SET TO SEK 4.90 PER UNIT
Source text for Eikon: ID:nWkrb81Vby
Further company coverage: EXPRS2.ST
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on ExpreS2ion Biotech Holding AB
See all newsBrief: Expres2ion Biotech To Raise SEK 19.3 Million From Warrants And Share Issue
Brief: ExpreS2ion Reports Q2 Loss Of SEK 9.7 Million
Brief: Expres2ion Biotech Says DSMB Recommends Expanding 450 Μg Cohort
Brief: Expres2ion Biotech Holding Q1 2026 Operating Income SEK 6.87 Mln
Brief: Expres2ion Updates ES2B-C001 Phase I Programme and Reports Additional Preliminary Immunogenicity and Safety Observations